Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.
Tseng JE, Glisson BS, Khuri FR, Shin DM, Myers JN, El-Naggar AK, Roach JS, Ginsberg LE, Thall PF, Wang X, Teddy S, Lawhorn KN, Zentgraf RE, Steinhaus GD, Pluda JM, Abbruzzese JL, Hong WK, Herbst RS. Tseng JE, et al. Among authors: pluda jm. Cancer. 2001 Nov 1;92(9):2364-73. doi: 10.1002/1097-0142(20011101)92:9<2364::aid-cncr1584>;2-p. Cancer. 2001. PMID: 11745292 Clinical Trial.
New targets for cancer chemotherapy.
Arbuck SG, Dancey J, Pluda JM, Grochow L, Murgo AJ, Ivy P, Wright J, Blaylock B, Via LE, Sausville EA. Arbuck SG, et al. Among authors: pluda jm. Cancer Chemother Biol Response Modif. 2001;19:237-88. Cancer Chemother Biol Response Modif. 2001. PMID: 11686017 Review. No abstract available.
88 results